ATTD-ASIA 2024, held recently in Singapore, was a huge success, with nearly 800 delegates from 49 countries gracing the event. ATTD-Asia 2024 chair, Professor Moshe Phillip, said the event brought together top diabetes experts to ensure patients can access the latest technologies and treatments for diabetes. MIMS Doctor reports highlights and snippets from the conference. Resources

A remote screening method using a wearable ECG patch yields a modest increase in atrial fibrillation (AF) diagnoses among older adults at risk of stroke, according to the AMALFI trial. The rate of AF detection at 2.5 years was 6.8 percent in the ECG patch arm vs 5.4 percent in the usual care arm, translating …

Remote AF screening with ECG patch nudges up diagnosis numbers Read More »

Prof Ulf Landmesser Treatment with inclisiran, on top of individually optimized lipid-lowering therapy (ioLLT), resulted in the achievement of guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals among patients with hypercholesterolaemia at high or very high risk of cardiovascular (CV) events, according to the VICTORION-Difference trial presented at ESC 2025. “The study met its primary endpoint, demonstrating the superiority …

Inclisiran-based strategy achieves LDL-C goals in patients at high CV risk Read More »